Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Davidson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Environmental Management|December 31, 2002
Capital assets and intercultural borderlands: socio-cultural challenges for natural resource managementElaine Stratford, Julie Davidson
Paediatric Nursing|November 9, 2005
Staff nurse development programme: evaluationJulie Davidson, Edward Glasper, Pauline Donaldson
Journal of Acquired Immune Deficiency Syndromes (1999)|May 31, 2018
Utility of the National Death Index in Identifying Deaths in a Clinic-Based, Multisite Cohort: The Experience of the Pediatric HIV/AIDS Cohort StudyJulie Alperen, Julie Davidson, Suzanne Siminski, et al.
Journal of Autism and Developmental Disorders|March 3, 2012
Expression of the broad autism phenotype in simplex autism families from the Simons Simplex CollectionJulie Davidson, Robin P Goin-Kochel, Lee Anne Green-Snyder, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Environmental Management|December 31, 2002
Capital assets and intercultural borderlands: socio-cultural challenges for natural resource managementElaine Stratford, Julie Davidson
Paediatric Nursing|November 9, 2005
Staff nurse development programme: evaluationJulie Davidson, Edward Glasper, Pauline Donaldson
Journal of Acquired Immune Deficiency Syndromes (1999)|May 31, 2018
Utility of the National Death Index in Identifying Deaths in a Clinic-Based, Multisite Cohort: The Experience of the Pediatric HIV/AIDS Cohort StudyJulie Alperen, Julie Davidson, Suzanne Siminski, et al.
Journal of Autism and Developmental Disorders|March 3, 2012
Expression of the broad autism phenotype in simplex autism families from the Simons Simplex CollectionJulie Davidson, Robin P Goin-Kochel, Lee Anne Green-Snyder, et al.
Plos One|November 3, 2016
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisDelphine Bachelet, Signe Hässler, Cyprien Mbogning, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
Pageof 1